Delivery Order SPE2DR25D2104-SPE2DR26F3QAK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,533.62 to AmerisourceBergen Drug Corp on November 20, 2025, under the Pharmaceutical PV Division contract. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The order is a child contract issued against AmerisourceBergen's larger indefinite delivery contract vehicle and is scheduled for completion by November 21, 2025. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $1,460.13 to AmerisourceBergen Drug Corp on December 9, 2025, for pharmaceutical products under the Pharmaceutical Prime Vendor Division. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025. As a child contract, this delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $1,436.74 to AmerisourceBergen Drug Corp on December 8, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed-price contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order falls under the Pharmaceutical Prime Vendor program, which...
- The Defense Logistics Agency awarded a delivery order valued at $1,178.89 to AmerisourceBergen Drug Corp on December 2, 2025, under the Pharmaceutical PV Division contract. This delivery order, issued on a firm fixed-price basis without set-aside restrictions, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $2,387.63 to AmerisourceBergen Drug Corp on December 9, 2025, under the Pharmaceutical PV DIV-FSB contract vehicle. This firm fixed-price delivery order, with a completion date of December 31, 2025, represents a child order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $2,469.78 to AmerisourceBergen Drug Corp on November 15, 2025, under its Pharmaceutical Prime Vendor contract. This firm fixed price delivery order is set to be completed by November 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA, which provides comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $2,744.18 to AmerisourceBergen Drug Corp on December 9, 2025, under the Pharmaceutical Prime Vendor Division contract. This firm fixed-price delivery order, which is not set-aside and issued on a competitive basis, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $1,829.52 to AmerisourceBergen Drug Corp on December 8, 2025, under the Pharmaceutical PV Division contract with an ultimate completion date of December 9, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,028.55 on November 24, 2025, under a Defense Logistics Agency (DLA) contract. This firm fixed-price, competitively awarded delivery order with an ultimate completion date of November 25, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitively set delivery order valued at $10,396.92 by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025, with an ultimate completion date of September 9, 2025. The contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3QAKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,170.45 to AmerisourceBergen Drug Corp on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed price delivery order, issued under the Pharmaceutical PV (Prime Vendor) Division contract, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract involves pharmaceutical supply delivery to the Conshohocken, Pennsylvania location, with no set-aside designation applied. As a competitively awarded contract, this delivery order reflects the continuation of AmerisourceBergen's role as a critical federal pharmaceutical distributor supporting military and defense healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds a significant $999,999,999.00 indefinite delivery vehicle with DLA Troop Support Medical that extends through December 2026. This comprehensive global pharmaceutical support contract enables the company to supply a broad range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, specialty treatments, and medical devices across multiple therapeutic domains. The delivery order referenced here exemplifies the company's ongoing role in supporting federal medical supply needs through the DLA's Medical Supply Chain, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/1/25 |